CoChat

High-Dose Daptomycin Therapy for Left-Sided Infective Endocarditis: a Prospective Study from the International Collaboration on Endocarditis

Open access
Carugati, Manuela, Bayer, Arnold S., Miró, Josè M., Park, Lawrence P., Guimarães, Armenio C., Skoutelis, Athanasios, Fortes, Claudio Q., Durante-Mangoni, Emanuele, Hannan, Margaret M., Nacinovich, Francisco, Fernández-Hidalgo, Nuria, Grossi, Paolo, Tan, Ru-San, Holland, Thomas, Fowler, Vance G., Corey, Ralph G., Chu, Vivian H. · 2013 · Antimicrobial Agents and Chemotherapy

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

The use of daptomycin in Gram-positive left-sided infective endocarditis (IE) has significantly increased. The purpose of this study was to assess the influence of high-dose daptomycin on the outcome of left-sided IE due to Gram-positive pathogens. This was a prospective cohort study based on 1,112 cases from the International Collaboration on Endocarditis (ICE)-Plus database and the ICE-Daptomycin Substudy database from 2008 to 2010. Among patients with left-sided IE due to Staphylococcus aureus , coagulase-negative staphylococci, and Enterococcus faecalis , we compared those treated with daptomycin (cohort A) to those treated with standard-of-care (SOC) antibiotics (cohort B). The primary outcome was in-hospital mortality. Time to clearance of bacteremia, 6-month mortality, and adverse events (AEs) ascribable to daptomycin were also assessed. There were 29 and 149 patients included in cohort A and cohort B, respectively. Baseline comorbidities did not differ between the two cohorts, except for a significantly higher prevalence of diabetes and previous episodes of IE among patients treated with daptomycin. The median daptomycin dose was 9.2 mg/kg of body weight/day. Two-thirds of the patients treated with daptomycin had failed a previous antibiotic regimen. In-hospital and 6-month mortalities were similar in the two cohorts. In cohort A, median time to clearance of methicillin-resistant S. aureus (MRSA) bacteremia was 1.0 day, irrespective of daptomycin dose, representing a significantly faster bacteremia clearance compared to SOC (1.0 versus 5.0 days; P < 0.01). Regimens with higher daptomycin doses were not associated with increased incidence of AEs. In conclusion, higher-dose daptomycin may be an effective and safe alternative to SOC in the treatment of left-sided IE due to common Gram-positive pathogens.

Overview

Integrity signals

Registry

Crossref · 10.1128/aac.01563-13

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 30 references

Cited by

See all 110

Metadata

Authors
Carugati, M., Bayer, A. S., Miró, J. M., Park, L. P., Guimarães, A. C., Skoutelis, A., Fortes, C. Q., Durante-Mangoni, E., Hannan, M. M., Nacinovich, F., Fernández-Hidalgo, N., Grossi, P., Tan, R.-S., Holland, T., Fowler, V. G., Corey, R. G., & Chu, V. H.
Affiliations
  • University of Milan (IT)
  • University of California, Los Angeles (US)
  • Infectious Diseases Service, Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain
  • Duke Medical Center (US)
  • Escola Bahiana de Medicina e Saúde Pública, Salvador, Brazil
  • Evangelismos Hospital (GR)
  • Clementino Fraga Filho Hospital, Rio de Janeiro, Brazil
  • University of Naples S.U.N., Monaldi Hospital, Naples, Italy
  • Mater Misericordiae University Hospital (IE)
  • Instituto Cardiovascular de Buenos Aires (AR)
  • Servei de Malalties Infeccioses, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain
  • University of Insubria (IT)
  • National Heart Centre Singapore (SG)
Venue
Antimicrobial Agents and Chemotherapy
Published
2013-12
Volume
57
Issue
12
Pages
6213-6222
ISSN
  • 0066-4804 (ISSN-L)
  • 1098-6596
OpenAlex
W1978437183
Cited by
100
References
30
Citations by year
2026: 3 · 2025: 4 · 2024: 5 · 2023: 5 · 2022: 6 · 2021: 7 · 2020: 6 · 2019: 7 · 2018: 6 · 2017: 10 · 2016: 11 · 2015: 19 · 2014: 11
FWCI
9.96
Type
journal article
Language
en
Open access
Licence
journals.asm.org/non-commercial-tdm-license (tdm)
Locations
  • Antimicrobial Agents and Chemotherapy (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • IrInSubria (University of Insubria) (submittedVersion)
  • Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
Funders
National Institute of Allergy and Infectious Diseases (K24AI093969)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
  • Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
Keywords
daptomycin, high-dose daptomycin, left-sided endocarditis, Staphylococcus aureus, coagulase-negative staphylococci, Enterococcus faecalis, methicillin-resistant Staphylococcus aureus, bacteremia clearance, in-hospital mortality, adverse events, antibiotic treatment failure
MeSH terms
Aged, Anti-Bacterial Agents, Endocarditis, Bacterial, Female, Humans, Male, Middle Aged, Prospective Studies, Staphylococcus aureus, Enterococcus faecalis, Daptomycin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: High-Dose Daptomycin Therapy for Left-Sided Infective Endocarditis: a Prospective Study from the International Collaboration on Endocarditis. https://app.cochat.ai/papers/10.1128/aac.01563-13
The paper
Carugati, M., Bayer, A. S., Miró, J. M., Park, L. P., Guimarães, A. C., Skoutelis, A., Fortes, C. Q., Durante-Mangoni, E., Hannan, M. M., Nacinovich, F., Fernández-Hidalgo, N., Grossi, P., Tan, R.-S., Holland, T., Fowler, V. G., Corey, R. G., & Chu, V. H. (2013). High-Dose Daptomycin Therapy for Left-Sided Infective Endocarditis: a Prospective Study from the International Collaboration on Endocarditis. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01563-13

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.